Post-Authorisation Safety Cohort Observation of Retacrit™ (epoetin zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO II) (PASCOII)

09/07/2013
22/02/2024
EU PAS number:
EUPAS4276
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

PASCO II Protocol Version 4.0_20 March 2015_Signed

English (550.3 KB - PDF) View document
Updated protocol

C1111006 Protocol Amendment 4 (clean) 02 August 2019

First published: 22/02/2024
English (1.75 MB - PDF) View document
Study results
Study results

epoe-09-11-abstract

English (1.89 MB - PDF) View document
Study report
Study report

epoe-09-11-report-body

English (8.5 MB - PDF) View document
Other information